ARCHIVES

In Brief: Upton Still Pondering Location Of Centers, Other Program; Moves Could Involve DCCR

This article is from The Cancer Letter archive.

Vol. 05 No. 17 | April 27, 1979

Download PDF Visit The Full Archive

Related Articles

Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease

December 28, 2012

Clearinghouse Role Broadened By Upton; Asked To Consider All Data In Risk Assessment

November 11, 1977

LeMaistre Blasts “Death Merchants’ In tobacco Industry

May 5, 1989

Tissue of Origin Test Consistent With Diagnosis In Blinded Validation Study

January 28, 2011

NIH News: NTP To test Herbs for Toxicity

August 13, 1999

House DoD Report Provides $15 Million For Lung Cancer Screening

October 23, 2009